Connect Biopharma Holdings Limited (CNTB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -11.25M | -12.59M | -15.58M | -8.29M | -16.84M | -31.09M | -44.49M | -52.85M | -45.66M | -39.08M | -17.49K | -6.55M |
| Operating CF Margin % | - | -26231.25% | -2231.72% | -34.36% | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 27.78% | -51.96% | 7.51% | 73.35% | 62.14% | 41.18% | 2.56% | -35.24% | -260913.12% | - | 99.73% | - |
| Net Income | -15.11M | -12.9M | -23.22M | 6.15M | -31.63M | -30.58M | -56.68M | -61.92M | -56.65M | -145.71M | -107.85K | -12.23M |
| Depreciation & Amortization | 181K | 171K | 184K | 326K | 481.87K | 506.13K | 527.3K | 502.72K | 412.05K | 221.39K | 161 | 57.3K |
| Stock-Based Compensation | 917K | 951K | 4.89M | 3.31M | 3.1M | 1.11K | 1.43K | 2.08K | 2.9K | 1.5K | 3.62K | 281.09K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -1.46M | -505.24K | 2.12M | 0 | 0 | 0 | 4.15M |
| Other Non-Cash Items | -64K | -288K | 126.13K | -99K | 9.8K | 2.16M | 10.74M | 856.07K | 691.6K | 108.04M | 86.08K | 3.85K |
| Working Capital Changes | 2.83M | -526K | 2.44M | -17.97M | 11.2M | -1.72M | 1.43M | 5.59M | 4.19M | -954.98K | 504 | 1.19M |
| Change in Receivables | 4K | 8K | 2.43M | -3.93M | 1.51M | -461.4K | 3.54M | -237.78K | 4.07M | -6.57M | -469 | -220 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 220 |
| Change in Payables | -30K | 1.48M | 96.79K | -1.68M | -4.29M | 15K | -2.99M | 3.36M | 2.46M | 6.34M | 0 | 1.4M |
| Cash from Investing | 10.98M | 5.13M | -15.72M | 12.46M | 40.9M | 34.25M | -6M | -75.81M | -257.55K | -5.03M | -211 | -242.35K |
| Capital Expenditures | -16K | -303K | 416K | -290K | -8.33K | -285.67K | -2.46M | -1.74M | -315.65K | -7.07M | -2.24K | -77.76K |
| CapEx % of Revenue | - | 631.25% | 59.6% | 1.2% | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | -2.94M | 0 | 2.96M | -16.5K | 6.12K | 35.82K | 0 | 0 | 0 | 165 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 2.26M | 0 | -100.5K | 16.5K | -6.12K | -35.82K | 56 | -703 | 2.03K | -165 |
| Cash from Financing | 715K | 161K | 272.42K | 121K | -115.72K | -130.28K | -124.69K | 35.18K | 979.46K | 203.66M | 140.78K | -28.73K |
| Debt Issued (Net) | 0 | 0 | 290K | 0 | -290K | 0 | 0 | 0 | 0 | 0 | 0 | -31.8K |
| Equity Issued (Net) | 715K | 161K | 124.42K | 121K | 44K | 0 | 0 | 0 | 1.13M | 220.97M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.46K | -195 | 0 | 0 |
| Other Financing | 0 | 0 | -142K | 0 | 130.28K | -61K | -59.03K | 35.18K | -6.18M | -17.3M | 140.78K | 3.5K |
| Net Change in Cash | 500K | -7.08M | -31.94M | 28.99M | -81.61M | 2.02M | -62.57M | -126.09M | -45.59M | 159.55M | 57.12K | -13.44M |
| Free Cash Flow | -11.27M | -12.89M | -15.89M | -8.41M | -16.85M | -31.37M | -46.94M | -54.59M | -45.97M | -46.15M | -19.73K | -6.62M |
| FCF Margin % | - | -26862.5% | -2276.43% | -34.87% | - | - | - | - | - | - | - | - |
| FCF Growth % | 29.1% | -53.32% | 5.71% | 73.19% | 64.1% | 42.53% | -2.12% | -18.28% | -232900.14% | - | 99.7% | - |
| FCF per Share | -0.20 | -0.23 | -0.29 | -0.15 | -0.31 | -0.57 | -0.85 | -0.99 | -0.86 | -0.98 | -0.00 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.98x | 1.75x | -0.56x | 0.53x | 1.02x | 0.78x | 0.88x | 0.81x | 0.27x | 0.16x | 0.55x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 168K | 0 | -120K | 0 | 120K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |